Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q1 2024 data
Van Leeuwen & Company, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

Van Leeuwen & Company, LLC

โ€ขCIK: 1769031โ€ขFiling: Q1 2024

**Van Leeuwen & Company, LLC** manages $197M across a concentrated portfolio of 88 positions. The fund exhibits significant exposure to technology and established growth names, highlighted by top holdings including MSFT ($9.1M) and GOOG ($7.7M). Further allocations are notable in financial services (V at $6.8M) and biotechnology (VRTX at $6.7M). This structure suggests a conviction-driven approach targeting large-cap secular growth trends.

Total AUM
$197.3M
QoQ Performance
-11.8%
Positions
81
Top 10 Concentration
34.2%
Latest Filing
Q1 2024

Top Holdings Allocation

MSFT4.6%
GOOG3.9%
BRK/B3.6%
V3.4%
VRTX3.4%
ROST3.4%
HUBB3.3%
NVDA3.2%

๐Ÿ“ˆ Biggest Buys

QCOM
QUALCOMM INC
NEW
2.2% of portfolio
GQ9
SPDR GOLD TR
NEW
1.6% of portfolio
HUBB
HUBBELL INC
+87.1%
3.3% of portfolio
CI
THE CIGNA GROUP
NEW
1.1% of portfolio
APP
APPLOVIN CORP
NEW
1.1% of portfolio

๐Ÿ“‰ Biggest Sells

AAPL
APPLE INC
-24.7%
2.9% of portfolio
UNH
UNITEDHEALTH GROUP INC
-45.0%
0.9% of portfolio
GOOG
ALPHABET INC
-10.7%
3.9% of portfolio
VST
VISTRA CORP
-49.8%
0.3% of portfolio
DELL
DELL TECHNOLOGIES INC
-20.0%
1.1% of portfolio

Sector Breakdown

Other48.3%
Technology23.6%
Financial9.8%
Healthcare7.0%
Consumer5.8%
Industrial2.2%
ETF1.8%
Communication1.3%

๐Ÿšช Exited Positionssold since Q4 2023

VUG
VANGUARD INDEX FDS
SOLD
$5.9M
PFE
PFIZER INC
SOLD
$5.0M
ON
ON SEMICONDUCTOR CORP
SOLD
$3.8M
T
AT&T INC
SOLD
$3.4M
ABBV
VERTEX PHARMACEUTICALS INC
SOLD
$3.1M
+35 more exited positions

Changes from Q4 2023

NEW12 new positions
โ†‘35 increased
โ†“36 decreased

Historical Filings

Q1 2024Q4 2023